SCHEMBL20737153

SCHEMBL20737153

CCCc1nc2ccccc2n1-c1ccc(-c2cc3c(c4ccccc24)-c2ccc4ccccc4c2C32c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.38
PDE10A Q9Y233 2/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PPARG P37231 5/20 0.35
USP2 O75604 1/20 0.35
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
BLM P54132 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HKDC1 Q2TB90 1/20 0.33
LMNA P02545 2/20 0.33
FLT3 P36888 1/20 0.33
MAPK1 P28482 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20737162 0.93 PDE10A (0.36) CYP1A2PDE10AMEN1KMT2ACNR1
SCHEMBL20735973 0.92 USP2 (0.38) CYP1A2PDE10AMEN1KMT2ACYP3A4
SCHEMBL27250490 0.90 CYP1A2 (0.39) CYP1A2PDE10AMEN1KMT2ACYP3A4
SCHEMBL27250554 0.89 PDE10A (0.36) CYP1A2PDE10AMEN1KMT2ACYP3A4
SCHEMBL27250373 0.89 CYP1A2 (0.38) CYP1A2PDE10AMEN1KMT2ACYP3A4
SCHEMBL20737211 0.88 CYP1A2 (0.39) CYP1A2PDE10AMEN1KMT2ACYP3A4
SCHEMBL20737172 0.87 MAPK1 (0.42) CYP1A2PDE10ASMN1; SMN2FLT3MAPK1
SCHEMBL20737170 0.86 PDE10A (0.39) CYP1A2PDE10AMEN1KMT2ACYP3A4
SCHEMBL27250576 0.85 PDE10A (0.37) CYP1A2PDE10AMEN1KMT2ACYP3A4
SCHEMBL27250463 0.85 CYP1A2 (0.38) CYP1A2PDE10AMEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 CYP1A2 739/4885PDE10A 4099/4885MEN1 635/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 CYP1A2 739/4885PDE10A 4099/4885MEN1 635/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 CYP1A2 739/4885PDE10A 4099/4885MEN1 635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.